Close

Sensus Healthcare (SRTS) Clearance to Sell SRT-100 in China for Treatment and Prevention of Keloids

July 26, 2017 7:44 AM EDT Send to a Friend
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login